name,assay,cellType,dataSubtype,dataType,diagnosis,individualID,individualIdSource,nf1Genotype,nf2Genotype,isCellLine,isMultiIndividual,isMultiSpecimen,isPrimaryCell,organ,sex,species,specimenID,specimenIdSource,tissue,experimentalCondition,experimentalTimePoint,timePointUnit,genePerturbationTechnology,genePerturbationType,genePerturbed,compoundDose,compoundDoseUnit,compoundDoseRange,compoundName,drugScreenType,secondCompoundName,fileFormat,resourceType,analysisType,isStranded,libraryPrep,readLength,readPairOrientation,readStrandOrigin,multipleTestingAdjustmentMethod,differentialExpressionMethod,alignmentMethod,runType,platform,transcriptQuantificationMethod,dataFileHandleId,chemicalStructure,structureType,studyId,studyName,createdOn,readPair,id,modelSystemName,createdBy,etag,type,currentVersion,parentId,benefactorId,projectId,modifiedOn,modifiedBy,tumorType,dataFileBucket,description,dataFileSizeBytes
GSK458_mouse_data_standardized.csv,in vivo bioluminescence,NA,raw,volume,Neurofibromatosis type 2,NA,NA,NA,NA,No,Yes,Yes,NA,NA,NA,Mus musculus,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GSK2126458,Panobinostat,CUDC907",NA,NA,csv,experimentalData,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,38445175,NA,NA,syn2343195,Synodos NF2,1553205143636,NA,syn18457655,CB17 SCID/Ben-Men-1-LucB,3342573,0e79cdf8-223d-4f18-81e5-c4798993347e,file,2,syn18457654,syn2343195,syn2343195,1651537897216,3434950,,proddata.sagebase.org,NA,32195
GSK458_Panobinostat_CUDC907TreatmentData.xlsx,in vivo bioluminescence,NA,raw,volume,Neurofibromatosis type 2,NA,NA,NA,NA,No,Yes,Yes,NA,NA,NA,Mus musculus,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"GSK2126458,Panobinostat,CUDC907",NA,NA,excel,experimentalData,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,36795788,NA,NA,syn2343195,Synodos NF2,1553205148058,NA,syn18457656,CB17 SCID/Ben-Men-1-LucB,3342573,170b2f23-7a5d-4096-bdd4-ed422ab587c6,file,1,syn18457654,syn2343195,syn2343195,1651537897450,3434950,,proddata.sagebase.org,NA,42698
MK2206andBrigatinibAloneAndCombinationINTheBenMen1Model.xlsx,in vivo bioluminescence,Syn6,processed,volume,Neurofibromatosis type 2,NA,NA,NA,-/-,No,Yes,Yes,NA,NA,NA,Homo sapiens,1_V1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DMSO,MK-2206,Brigatinib,MK-2206+Brigatinib",NA,NA,excel,experimentalData,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,37483571,NA,NA,syn2343195,Synodos NF2,1553205152507,NA,syn18457657,CB17 SCID/Ben-Men-1-LucB,3342573,28cce3d7-94b8-4232-86e2-5ace523b448b,file,1,syn18457654,syn2343195,syn2343195,1651537897699,3434950,,proddata.sagebase.org,NA,25780
MK2206andBrigatinibCombinationAndBrigatinibAlonePostTxAndReTx.xlsx,in vivo bioluminescence,Syn6,processed,volume,Neurofibromatosis type 2,NA,NA,NA,-/-,No,Yes,Yes,NA,NA,NA,Homo sapiens,2_BM4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"DMSO,MK-2206,Brigatinib,MK-2206+Brigatinib",NA,NA,excel,experimentalData,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,37483570,NA,NA,syn2343195,Synodos NF2,1553205156878,NA,syn18457658,CB17 SCID/Ben-Men-1-LucB,3342573,37f87584-9582-46fb-9448-db92a89a8533,file,1,syn18457654,syn2343195,syn2343195,1651537897917,3434950,,proddata.sagebase.org,NA,41236
